What is MaxCyte's capex?

MaxCyte (MXCT) reported capex of $72K in Q1 2026.

How has MaxCyte's capex changed year-over-year?

MaxCyte's capex decreased by 89.0% year-over-year, from $653K to $72K.

What is the long-term trend for MaxCyte's capex?

Over 4 years (2021 to 2025), MaxCyte's capex has grown at a -17.6% compound annual growth rate (CAGR), from $3.83M to $1.77M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

MaxCyte MXCT CapEx

CapEx at other companies

Bio-Rad LaboratoriesBIO

$30M-12.8%

Thermo Fisher ScientificTMO

$376M+3.9%

Ginkgo BioworksDNA

$1.93M-74.6%

Immix Biopharma, Inc.IMMX

$32.49K-52.0%

Rapid Micro BiosystemsRPID

$394K+23.5%

PDE

Pro-Dex, Inc.PDEX

$112K-37.8%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's capex?: MaxCyte (MXCT) reported capex of $72K in Q1 2026.
How has MaxCyte's capex changed year-over-year?: MaxCyte's capex decreased by 89.0% year-over-year, from $653K to $72K.
What is the long-term trend for MaxCyte's capex?: Over 4 years (2021 to 2025), MaxCyte's capex has grown at a -17.6% compound annual growth rate (CAGR), from $3.83M to $1.77M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.